Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 186

1.

Role of extent of resection in the long-term outcome of low-grade hemispheric gliomas.

Smith JS, Chang EF, Lamborn KR, Chang SM, Prados MD, Cha S, Tihan T, Vandenberg S, McDermott MW, Berger MS.

J Clin Oncol. 2008 Mar 10;26(8):1338-45. doi: 10.1200/JCO.2007.13.9337.

PMID:
18323558
2.

The assessment of prognostic factors in surgical treatment of low-grade gliomas: a prospective study.

Majchrzak K, Kaspera W, Bobek-Billewicz B, Hebda A, Stasik-Pres G, Majchrzak H, Ładziński P.

Clin Neurol Neurosurg. 2012 Oct;114(8):1135-44. doi: 10.1016/j.clineuro.2012.02.054. Epub 2012 Mar 17.

PMID:
22425370
3.

Extent of surgical resection is independently associated with survival in patients with hemispheric infiltrating low-grade gliomas.

McGirt MJ, Chaichana KL, Attenello FJ, Weingart JD, Than K, Burger PC, Olivi A, Brem H, Quinoñes-Hinojosa A.

Neurosurgery. 2008 Oct;63(4):700-7; author reply 707-8. doi: 10.1227/01.NEU.0000325729.41085.73.

PMID:
18981880
4.

Results of a policy of surveillance alone after surgical management of pediatric low grade gliomas.

Fisher BJ, Leighton CC, Vujovic O, Macdonald DR, Stitt L.

Int J Radiat Oncol Biol Phys. 2001 Nov 1;51(3):704-10.

PMID:
11597812
5.

Insular glioma resection: assessment of patient morbidity, survival, and tumor progression.

Sanai N, Polley MY, Berger MS.

J Neurosurg. 2010 Jan;112(1):1-9. doi: 10.3171/2009.6.JNS0952.

PMID:
19612970
6.

The effect of extent of resection on recurrence in patients with low grade cerebral hemisphere gliomas.

Berger MS, Deliganis AV, Dobbins J, Keles GE.

Cancer. 1994 Sep 15;74(6):1784-91.

7.

Perfusion magnetic resonance imaging predicts patient outcome as an adjunct to histopathology: a second reference standard in the surgical and nonsurgical treatment of low-grade gliomas.

Law M, Oh S, Johnson G, Babb JS, Zagzag D, Golfinos J, Kelly PJ.

Neurosurgery. 2006 Jun;58(6):1099-107; discussion 1099-107.

PMID:
16723889
8.

Updated therapeutic strategy for adult low-grade glioma stratified by resection and tumor subtype.

Nitta M, Muragaki Y, Maruyama T, Iseki H, Ikuta S, Konishi Y, Saito T, Tamura M, Chernov M, Watanabe A, Okamoto S, Maebayashi K, Mitsuhashi N, Okada Y.

Neurol Med Chir (Tokyo). 2013;53(7):447-54.

9.

Low-grade glioma surgery in eloquent areas: volumetric analysis of extent of resection and its impact on overall survival. A single-institution experience in 190 patients: clinical article.

Ius T, Isola M, Budai R, Pauletto G, Tomasino B, Fadiga L, Skrap M.

J Neurosurg. 2012 Dec;117(6):1039-52. doi: 10.3171/2012.8.JNS12393. Epub 2012 Oct 5.

PMID:
23039150
10.

Clinical outcome of surgically treated low-grade gliomas: a retrospective analysis of a single institute.

Turkoglu E, Gurer B, Sanli AM, Dolgun H, Gurses L, Oral NA, Donmez T, Sekerci Z.

Clin Neurol Neurosurg. 2013 Dec;115(12):2508-13. doi: 10.1016/j.clineuro.2013.10.010. Epub 2013 Oct 25.

PMID:
24225484
11.

Early prognostic factors related to progression and malignant transformation of low-grade gliomas.

Jung TY, Jung S, Moon JH, Kim IY, Moon KS, Jang WY.

Clin Neurol Neurosurg. 2011 Nov;113(9):752-7. doi: 10.1016/j.clineuro.2011.08.002. Epub 2011 Sep 1.

PMID:
21889256
12.

Combined treatment modality for anaplastic oligodendroglioma and oligoastrocytoma: a 10-year update of a phase II study.

Jeremic B, Milicic B, Grujicic D, Samardzic M, Antunovic V, Dagovic A, Aleksandrovic J.

Int J Radiat Oncol Biol Phys. 2004 Jun 1;59(2):509-14.

PMID:
15145170
13.

Preoperative prognostic classification system for hemispheric low-grade gliomas in adults.

Chang EF, Smith JS, Chang SM, Lamborn KR, Prados MD, Butowski N, Barbaro NM, Parsa AT, Berger MS, McDermott MM.

J Neurosurg. 2008 Nov;109(5):817-24. doi: 10.3171/JNS/2008/109/11/0817.

PMID:
18976070
14.

Proposed therapeutic strategy for adult low-grade glioma based on aggressive tumor resection.

Nitta M, Muragaki Y, Maruyama T, Ikuta S, Komori T, Maebayashi K, Iseki H, Tamura M, Saito T, Okamoto S, Chernov M, Hayashi M, Okada Y.

Neurosurg Focus. 2015 Jan;38(1):E7. doi: 10.3171/2014.10.FOCUS14651.

PMID:
25599276
15.

Threshold of the extent of resection for WHO Grade III gliomas: retrospective volumetric analysis of 122 cases using intraoperative MRI.

Fujii Y, Muragaki Y, Maruyama T, Nitta M, Saito T, Ikuta S, Iseki H, Hongo K, Kawamata T.

J Neurosurg. 2017 Sep 8:1-9. doi: 10.3171/2017.3.JNS162383. [Epub ahead of print]

PMID:
28885120
16.

The impact of extent of resection and histological subtype on the outcome of adult patients with high-grade gliomas.

Yamaguchi S, Kobayashi H, Terasaka S, Ishii N, Ikeda J, Kanno H, Nishihara H, Tanaka S, Houkin K.

Jpn J Clin Oncol. 2012 Apr;42(4):270-7. doi: 10.1093/jjco/hys016. Epub 2012 Mar 6.

PMID:
22399670
17.

The impact of extent of resection on malignant transformation of pure oligodendrogliomas.

Snyder LA, Wolf AB, Oppenlander ME, Bina R, Wilson JR, Ashby L, Brachman D, Coons SW, Spetzler RF, Sanai N.

J Neurosurg. 2014 Feb;120(2):309-14. doi: 10.3171/2013.10.JNS13368. Epub 2013 Dec 6.

PMID:
24313617
18.

Volumetric Analysis of Extent of Resection, Survival, and Surgical Outcomes for Insular Gliomas.

Eseonu CI, ReFaey K, Garcia O, Raghuraman G, Quinones-Hinojosa A.

World Neurosurg. 2017 Jul;103:265-274. doi: 10.1016/j.wneu.2017.04.002. Epub 2017 Apr 10.

PMID:
28408263
19.

Supratentorial astrocytomas and oligodendrogliomas treated in the MRI era.

Sakata K, Hareyama M, Komae T, Shirato H, Watanabe O, Watarai J, Takai K, Yamada S, Tsuchida E, Sakai K.

Jpn J Clin Oncol. 2001 Jun;31(6):240-5.

PMID:
11463800
20.

Treatment outcomes and prognostic factors of patients with supratentorial low-grade oligodendroglioma.

Yeh SA, Lee TC, Chen HJ, Lui CC, Sun LM, Wang CJ, Huang EY.

Int J Radiat Oncol Biol Phys. 2002 Dec 1;54(5):1405-9.

PMID:
12459363

Supplemental Content

Support Center